Ingvild Odsbu

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ACTA PSYCHIATRICA SCANDINAVICA. 2024
Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study
Odsbu I; Hamina A; Hjellvik V; Handal M; Haram M; Tesli M; Tanskanen A; Taipale H
Article: JAMA NETWORK OPEN. 2024;7(11):e2445055
First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations
Nakitanda AO; Odsbu I; Cesta CE; Pazzagli L; Pasternak B
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(3):531-539
Antibiotic use during pregnancy in Sweden: A nationwide utilization study covering 2007-2019
Nakitanda AO; Odsbu I; Pasternak B; Karlsson P; Pazzagli L
Article: NEUROLOGY. 2024;102(2):e207996
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy
Cohen JM; Alvestad S; Suarez EA; Schaffer A; Selmer RM; Havard A; Bateman BT; Cesta CE; Zoega H; Odsbu I; Huybrechts KF; Kjerpeseth LJ; Straub L; Leinonen MK; Bjork M-H; Norgaard M; Gissler M; Ulrichsen SP; Hernandez-Diaz S; Tomson T; Furu K
Article: EUROPEAN JOURNAL OF PAIN. 2024;28(1):95-104
Socioeconomic risk factors for long-term opioid use: A national registry-linkage study.
Nestvold HH; Skurtveit SS; Hamina A; Hjellvik V; Odsbu I
Article: EUROPEAN JOURNAL OF PAIN. 2023;27(7):884-895
Mental disorder prevalence in chronic pain patients using opioid versus non-opioid analgesics: A registry-linkage study.
Gjerde LC; Skurtveit S; Handal M; Nesvåg R; Clausen T; Lid TG; Hamina A; Borchgrevink PC; Odsbu I
Article: SUBSTANCE ABUSE: TREATMENT, PREVENTION, AND POLICY. 2023;18(1):47
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway.
Rolová G; Eide D; Gabrhelík R; Odsbu I; Clausen T; Skurtveit S
Article: DRUG SAFETY. 2023;46(7):661-675
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries
Dudukina E; Szepligeti SK; Karlsson P; Asomaning K; Daltveit AK; Hakkarainen K; Hoti F; Kieler H; Lunde A; Odsbu I; Rantanen M; Reutfors J; Saarelainen L; Ehrenstein V; Toft G
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2023;29:100621
Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers
Pasman JA; Meijsen J; Haram M; Kowalec K; Harder A; Xiong Y; Nguyen T-D; Jangmo A; Shorter JR; Bergstedt J; Das U; Zetterberg R; Tate A; Lichtenstein P; Larsson H; Odsbu I; Werge T; Reichborn-Kjennerud T; Andreassen OA; Sullivan PF; Buil A; Tesli M; Lua Y
Article: DRUG SAFETY. 2023;46(5):467-478
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study
Njotto LL; Simin J; Fornes R; Odsbu I; Mussche I; Callens S; Engstrand L; Bruyndonckx R; Brusselaers N
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY MFM. 2023;5(4):100860
In-utero antibiotic exposure and subsequent infections in infancy: a register-based cohort study with sibling analysis
Nakitanda AO; Kieler H; Odsbu I; Rhedin S; Almqvist C; Pasternak B; Pazzagli L
Article: ANNALS OF NEUROLOGY. 2023;93(3):551-562
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations
Cohen JM; Alvestad S; Cesta CE; Bjork M-H; Leinonen MK; Norgaard M; Einarsdottir K; Engeland A; Gissler M; Karlstad O; Klungsoyr K; Odsbu I; Reutfors J; Selmer RM; Tomson T; Ulrichsen SP; Zoega H; Furu K
Article: EUROPEAN ADDICTION RESEARCH. 2023;29(4):272-284
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study.
Eide D; Skurtveit S; Clausen T; Hesse M; Mravčík V; Nechanská B; Rolova G; Thylstrup B; Tjagvad C; Seid AK; Odsbu I; Gabrhelík R
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1056192
Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden
Odsbu I; Handal M; Hjellvik V; Hernandez-Diaz S; Kieler H; Norgaard M; Skurtveit S; Esen BO; Mahic M
Article: BMC INFECTIOUS DISEASES. 2022;22(1):492
Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
Nakitanda AO; Karlsson P; Lofling L; Cesta CE; Odsbu I
Article: BMC GERIATRICS. 2022;22(1):429
Prescription opioids among older adults: ten years of data across five countries
Hamina A; Muller AE; Clausen T; Skurtveit S; Hesse M; Tjagvad C; Thylstrup B; Odsbu I; Zoega H; Jonsdottir HL; Taipale H
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2022;130(4):481-491
Describing long-term opioid use utilizing Nordic prescription registers-A Norwegian example.
Hamina A; Hjellvik V; Handal M; Odsbu I; Clausen T; Skurtveit S
Article: TIDSSKRIFT FOR DEN NORSKE LEGEFORENING. 2022;142(3)
[Changes in opioid use in Norway must be taken with the utmost seriousness].
Odsbu I; Handal M; Borchgrevink PC; Clausen T; Skurtveit S
Article: TIDSSKRIFT FOR DEN NORSKE LEGEFORENING. 2022;142(3)
[Long-term use of opioids and concomitant use of other habit-forming drugs].
Odsbu I; Handal M; Hjellvik V; Borchgrevink PC; Clausen T; Nesvåg R; Skurtveit S
Article: CLINICAL EPIDEMIOLOGY. 2022;14:1477-1486
Cohort Description: Preventing an Opioid Epidemic in Norway - Focusing on Treatment of Chronic Pain (POINT) - A National Registry-Based Study.
Hamina A; Odsbu I; Borchgrevink PC; Chen L-C; Clausen T; Espnes KA; Gjesdal K; Handal M; Hartikainen S; Hjellvik V; Holter MTS; Høibø T; Kurita GP; Langaas HC; Lid TG; Nøst TH; Sjøgren P; Skurtveit S; POINT study group
Article: EUROPEAN ADDICTION RESEARCH. 2022;28(6):419-424
Individuals Dying of Overdoses Related to Pharmaceutical Opioids Differ from Individuals Dying of Overdoses Related to Other Substances: A Population-Based Register Study.
Skurtveit S; Odsbu I; Gjersing L; Handal M; Lid TG; Clausen T; Hamina A
Article: PLOS ONE. 2022;17(8):e0272046
Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studies
Pazzagli L; Chacon SS; Karampelias C; Cohen JM; Broms G; Kieler H; Odsbu I; Selmer R; Andersson O; Cesta CE
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021;30(10):1447-1457
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe
Fortuny J; von Gersdorff G; Lassalle R; Linder M; Overbeek J; Reinold J; Toft G; Timmer A; Dress J; Blin P; Droz-Perroteau C; Ehrenstein V; Franzoni C; Herings R; Kollhorst B; Moore N; Odsbu I; Perez-Gutthann S; Schink T; Rascher K; Rasouliyan L; Rothman KJ; Saigi-Morgui N; Schaller M; Smits E; Forstner M; Benichou J; Bircher AJ; Garbe E; Rampton DS; Gutierrez L
Article: DRUG SAFETY. 2021;44(8):899-915
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Hoffman V; Hallas J; Linder M; Margulis AV; Suehs BT; Arana A; Phiri K; Enger C; Horter L; Odsbu I; Olesen M; Perez-Gutthann S; Xu Y; Kristiansen NS; Appenteng K; de Vogel S; Seeger JD
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2021;37(5):867-877
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder
Phiri K; Hallas J; Linder M; Margulis A; Suehs B; Arana A; Bahmanyar S; Hoffman V; Enger C; Horter L; Odsbu I; Olesen M; Perez-Gutthann S; Kristiansen NS; Appenteng K; de Vogel S; Seeger J
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(12):1562-1569
Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab
Srinivas C; Odsbu I; Linder M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(12):1596-1604
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study
Mahic M; Hernandez-Diaz S; Wood M; Kieler H; Odsbu I; Norgaard M; ozturk B; Bateman BT; Hjellvik V; Skurtveit S; Handal M
Article: BMJ OPEN. 2020;10(8):e036355
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
Aas CF; Vold JH; Skurtveit S; Odsbu I; Chalabianloo F; Okland JM; Leiva RAM; Vickerman P; Johansson KA; Fadnes LT
Article: BMJ OPEN. 2020;10(8):e036860
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
Vold JH; Aas C; Skurtveit S; Odsbu I; Chalabianloo F; Reutfors J; Halmoy A; Johansson KA; Fadnes LT
Article: SUBSTANCE ABUSE: TREATMENT, PREVENTION, AND POLICY. 2020;15(1):44
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
Aas CF; Vold JH; Skurtveit S; Odsbu I; Chalabianloo F; Lim AG; Johansson KA; Fadnes LT
Article: BMC PSYCHIATRY. 2020;20(1):119
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
Vold JH; Aas C; Skurtveit S; Odsbu I; Chalabianloo F; Halmoy A; Johansson KA; Fadnes LT
Article: DRUG SAFETY. 2019;42(10):1179-1190
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
Gilsenan A; Fortuny J; Cainzos-Achirica M; Cantero OF; Flynn RWV; Garcia-Rodriguez L; Harding A; Kollhorst B; Karlsson P; Linner L; MacDonald TM; Odsbu I; Plana E; Ruigomez A; Schink T; Ziemiecki R; Andrews EB
Article: SCANDINAVIAN JOURNAL OF PAIN. 2019;19(2):345-353
Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017
Muller AE; Clausen T; Sjogren P; Odsbu I; Skurtveit S
Article: CLINICAL INFECTIOUS DISEASES. 2019;68(8):1367-1373
Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-Cohort Study
Steens A; Winje BA; White RA; Odsbu I; Brantsaeter AB; Vestrheim DF
Article: BMJ OPEN DIABETES RESEARCH & CARE. 2019;7(1):e000759
Antidiabetic medication use during pregnancy: an international utilization study
Cesta CE; Cohen JM; Pazzagli L; Bateman BT; Broms G; Einarsdottir K; Furu K; Havard A; Heino A; Hernandez--Diaz S; Huybrechts KF; Karlstad O; Kieler H; Li J; Leinonen MK; Gulseth HL; Duong T; Yu Y; Zoega H; Odsbu I
Article: BMC MICROBIOLOGY. 2018;18(1):27
Mutations of DnaA-boxes in the oriR region increase replication frequency of the MiniR1-1 plasmid
Yao Y; Enkhtsetseg S; Odsbu I; Fan L; Morigen M
Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2018;15(1):E155-155
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014
Odsbu I; Khedkar S; Lind F; Khedkar U; Nerkar SS; Orsini N; Tamhankar AJ; Lundborg CS
Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2018;15(1):E153-153
High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates
Odsbu I; Khedkar S; Khedkar U; Nerkar SS; Tamhankar AJ; Lundborg CS
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2017;72(5):1510-1515
Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne
Odsbu I; Selmer R; Lundborg CS; Blix HS
Article: GENES. 2016;8(1):E1-1
A Spatial Control for Correct Timing of Gene Expression during the Escherichia coli Cell Cycle
Yao Y; Fan L; Shi Y; Odsbu I; Morigen
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2015;71(3):283-291
Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.
Odsbu I; Skurtveit S; Selmer R; Roth C; Hernandez-Diaz S; Handal M
Article: MICROBIOLOGY (UNITED KINGDOM). 2014;160(Pt 5):872-882
DNA compaction in the early part of the SOS response is dependent on RecN and RecA.
Odsbu I; Skarstad K
Article: PLOS GENETICS. 2013;9(2):e1003260
Single transmembrane peptide DinQ modulates membrane-dependent activities.
Weel-Sneve R; Kristiansen KI; Odsbu I; Dalhus B; Booth J; Rognes T; Skarstad K; Bjørås M
Article: JOURNAL OF CHROMATOGRAPHY A. 2011;1218(35):5981-5986
Hydrophilic interaction chromatography of nucleoside triphosphates with temperature as a separation parameter.
Johnsen E; Wilson SR; Odsbu I; Krapp A; Malerod H; Skarstad K; Lundanes E
Article: PLOS ONE. 2009;4(10):e7617
A reduction in ribonucleotide reductase activity slows down the chromosome replication fork but does not change its localization.
Odsbu I; Morigen; Skarstad K
Article: GENES TO CELLS. 2009;14(5):643-657
Growth rate dependent numbers of SeqA structures organize the multiple replication forks in rapidly growing Escherichia coli.
Morigen; Odsbu I; Skarstad K
Article: GENES TO CELLS. 2005;10(11):1039-1049
Specific N-terminal interactions of the Escherichia coli SeqA protein are required to form multimers that restrain negative supercoils and form foci.
Odsbu I; Klungsøyr HK; Fossum S; Skarstad K
Visa fler

Alla övriga publikationer

Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024;33(5):e5799
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program
de Vogel S; Seeger JD; Arana A; Margulis AV; McQuay LJ; Perez-Gutthann S; Hallas J; Kristiansen NS; Linder M; Odsbu I; Suehs B; Xu Y; Uribe C; Appenteng K; Robinson NJ

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI